pyrazinamide has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chi, X; Gao, C; Hu, YW; Huang, Z; Wang, Q; Zeng, T; Zheng, L | 1 |
| Chen, W; Ding, P; Guo, H; Han, L; Hassan, HM; He, Q; Hsiao, CD; Jiang, Z; Liu, K; Zhang, L; Zhang, Y | 1 |
| Bay, ML; Besedovsky, H; Bongiovanni, B; Bottasso, O; Brandan, N; D'Attilio, L; Del Rey, A; Díaz, A; Dídoli, G; Fernández, RDV; Gardeñez, W; Kovalevski, L; Lioi, S; Nannini, LJ; Santucci, N | 1 |
3 other study(ies) available for pyrazinamide and transforming growth factor beta
| Article | Year |
|---|---|
IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype.
Topics: Antitubercular Agents; Arginase; B7-2 Antigen; Cell Differentiation; Cells, Cultured; Ethambutol; Female; Humans; Interferon-gamma; Interleukin-1; Interleukin-10; Interleukin-12 Subunit p35; Isoniazid; Lectins, C-Type; Macrophages; Male; Mannose Receptor; Mannose-Binding Lectins; Middle Aged; Mycobacterium tuberculosis; Nitric Oxide; Phagocytosis; Phenotype; Pyrazinamide; Receptors, Cell Surface; Rifampin; RNA Interference; RNA, Messenger; RNA, Small Interfering; Transcriptional Activation; Transforming Growth Factor beta; Tuberculosis, Pulmonary; Up-Regulation | 2015 |
Liver Fatty Acid Binding Protein Deficiency Provokes Oxidative Stress, Inflammation, and Apoptosis-Mediated Hepatotoxicity Induced by Pyrazinamide in Zebrafish Larvae.
Topics: Animals; Animals, Genetically Modified; Antitubercular Agents; Apoptosis; Fatty Acid-Binding Proteins; Green Fluorescent Proteins; Hepatitis; Inflammation; Larva; Liver; Oxidative Stress; PPAR alpha; Pyrazinamide; Reactive Oxygen Species; Transaminases; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Zebrafish | 2016 |
The clinical recovery of tuberculosis patients undergoing specific treatment is associated with changes in the immune and neuroendocrine responses.
Topics: Adult; Antitubercular Agents; C-Reactive Protein; Case-Control Studies; Dehydroepiandrosterone; Ethambutol; Female; Gene Expression Regulation; Humans; Hydrocortisone; Interferon-gamma; Interleukin-6; Isoniazid; Leukocytes, Mononuclear; Male; Middle Aged; Mycobacterium tuberculosis; Pyrazinamide; Receptors, Glucocorticoid; Rifampin; Transforming Growth Factor beta; Treatment Outcome; Tuberculosis, Pulmonary | 2017 |